{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:11:29Z","timestamp":1770966689441,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1994,1]]},"DOI":"10.1007\/bf02090053","type":"journal-article","created":{"date-parts":[[2005,8,15]],"date-time":"2005-08-15T06:04:26Z","timestamp":1124085866000},"page":"9-14","source":"Crossref","is-referenced-by-count":18,"title":["Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease"],"prefix":"10.1007","volume":"39","author":[{"given":"A.","family":"Floreani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Zappal\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mazzetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Naccarato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Chiaramonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02090053_CR1","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0140-6736(87)91610-2","volume":"1","author":"R Poupon","year":"1987","unstructured":"Poupon R, Chretien Y, Poupon RE, Ballet F, Calmus Y, Darnis F: Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1:834\u2013836, 1987","journal-title":"Lancet"},{"key":"BF02090053_CR2","first-page":"15","volume":"85","author":"Y Matsuzaki","year":"1989","unstructured":"Matsuzaki Y, Tanaka N, Osuga T, Aikawa T, Shoda J, Doi M, Nakano M: Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis. Am J Gastroenterol 85:15\u201323, 1989","journal-title":"Am J Gastroenterol"},{"issue":"suppl","key":"BF02090053_CR3","doi-asserted-by":"crossref","first-page":"59S","DOI":"10.1007\/BF01536665","volume":"34","author":"M Podda","year":"1989","unstructured":"Podda M, Ghezzi C, Battezzati PM, Bertolini E, Crosignani A, Petroni ML, Zuin M: Effect of different doses of ursodeoxycholic acid in chronic liver disease. Dig Dis Sci 34(suppl):59S-65S, 1989","journal-title":"Dig Dis Sci"},{"key":"BF02090053_CR4","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0016-5085(89)91698-3","volume":"97","author":"U Leuschner","year":"1989","unstructured":"Leuschner U, Fischer H, Kurtz W, Guldutuna S, Hubner K, Hellstern A, Gatzen M, Leuschner M: Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology 97:1268\u20131274, 1989","journal-title":"Gastroenterology"},{"key":"BF02090053_CR5","first-page":"580","volume":"10","author":"SL Hadziyannis","year":"1989","unstructured":"Hadziyannis SL, Hadziyannis ES, Makris A: A randomized controlled trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC). Hepatology 10:580, A45, 1989","journal-title":"Hepatology"},{"key":"BF02090053_CR6","first-page":"639","volume":"10","author":"M Podda","year":"1989","unstructured":"Podda M, Battezzati PM, Crosignani A, Bianchi FB, Fusconi M, Chiaramonte M, Floreani A, Orlandi F, Macarri GP, Surrenti C, Pozzi M, Pagliaro L, Almasio P, Manenti F, Tabarroni G: Ursodeoxycholic acid (UDCA) for symptomatic primary biliary cirrhosis (PBC): A double-blind multicenter trial. Hepatology 10:639, A-284, 1989","journal-title":"Hepatology"},{"key":"BF02090053_CR7","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","volume":"30","author":"RE Poupon","year":"1991","unstructured":"Poupon RE, Balkau B, Eschwege E, Poupon R, UDCA-PBC Study Group: A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 30:1548\u20131554, 1991","journal-title":"N Engl J Med"},{"key":"BF02090053_CR8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000171236","volume":"8","author":"U Leuschner","year":"1990","unstructured":"Leuschner U, Kurtz W: Pharmacological aspects and therapeutic effects of ursodeoxycholic acid. Dig Dis 8:12\u201322, 1990","journal-title":"Dig Dis"},{"key":"BF02090053_CR9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(88)91974-5","volume":"1","author":"W Vogel","year":"1988","unstructured":"Vogel W, Katrein H, Judlmeier G, Braunsteiner H: Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid. Lancet 1:1163, 1988","journal-title":"Lancet"},{"key":"BF02090053_CR10","first-page":"1257","volume":"60","author":"PJ Scheuer","year":"1967","unstructured":"Scheuer PJ: Primary biliary cirrhosis. Proc R Soc Med 60:1257\u20131260, 1967","journal-title":"Proc R Soc Med"},{"key":"BF02090053_CR11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0009-8981(74)90243-5","volume":"54","author":"GP Berge-Henegouwen Van","year":"1974","unstructured":"Van Berge-Henegouwen GP, Ruben A, Brandt K-H: Quantitative analysis of bile acids in serum and bile using gasliquid chromatography. Clin Chim Acta 54:249\u2013261, 1974","journal-title":"Clin Chim Acta"},{"key":"BF02090053_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","volume":"10","author":"ER Dickson","year":"1984","unstructured":"Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 10:1\u20137, 1984","journal-title":"Hepatology"},{"key":"BF02090053_CR13","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0016-5085(19)31870-0","volume":"73","author":"CN Ghent","year":"1978","unstructured":"Ghent CN, Bloomer JR, Klatsin G: Elevation in skin tissue levels of bile acid in human cholestasis: Relation to serum levels and to pruritus. Gastroenterology 73:1125\u20131130, 1978","journal-title":"Gastroenterology"},{"key":"BF02090053_CR14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0016-5085(80)90571-5","volume":"76","author":"E Christensen","year":"1980","unstructured":"Christensen E, Crowe J, Doniach D, Popper H, Ranek L, Rodes J, Tygstrup N, Williams R: Clinical pattern and course of disease in PBC based on analysis of 236 patients. Gastroenterology 76:236\u2013246, 1980","journal-title":"Gastroenterology"},{"key":"BF02090053_CR15","first-page":"370","volume":"2","author":"JM Shapiro","year":"1982","unstructured":"Shapiro JM, Smith H, Schaffner C: Serum bilirubin: A prognostic factor in primary biliary cirrhosis. J Hepatol 2:370\u2013378, 1982","journal-title":"J Hepatol"},{"key":"BF02090053_CR16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/hep.1840080127","volume":"8","author":"A Nyberg","year":"1988","unstructured":"Nyberg A, Engstrom-Laurent A, Loof L: Serum hyaluronate in primary biliary cirrhosis. A biochemical marker for progressive liver damage. Hepatology 8:142\u2013146, 1988","journal-title":"Hepatology"},{"key":"BF02090053_CR17","first-page":"79","volume":"107","author":"JRE Fraser","year":"1986","unstructured":"Fraser JRE, Engstrom-Laurent A, Nyberg A, Laurent TC: Removal of hyaluronic acid from the circulation in rheumatoid disease and primary biliary cirrhosis. J Lab Clin Med 107:79\u201385 1986","journal-title":"J Lab Clin Med"},{"key":"BF02090053_CR18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/hep.1840050420","volume":"5","author":"A Engstrom-Laurent","year":"1985","unstructured":"Engstrom-Laurent A, Loof L, Nyberg A, Schroder T: Increased serum levels of hyaluronate in liver disease. Hepatology 5:638\u2013642, 1985","journal-title":"Hepatology"},{"key":"BF02090053_CR19","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/hep.1840040505","volume":"4","author":"A Frei","year":"1984","unstructured":"Frei A, Zimmermann A, Weigand K: TheN-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease. Hepatology 4:830\u2013834, 1984","journal-title":"Hepatology"},{"key":"BF02090053_CR20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/hep.1840040506","volume":"4","author":"K Weigand","year":"1984","unstructured":"Weigand K, Zaugg PY, Frei A, Zimmermann A: Long-term follow-up of serumN-terminal propeptide of collagen type III in patients with chronic liver disease. Hepatology 4:835\u2013838, 1984","journal-title":"Hepatology"},{"key":"BF02090053_CR21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0168-8278(86)80049-6","volume":"2","author":"G Annoni","year":"1986","unstructured":"Annoni G, Cargnel A, Colombo M, Hahn EG: Persistent elevation of the aminoterminal peptide of procollagen type III in serum in patients with acute viral hepatitis distinguishes chronic active hepatitis from resolving or chronic persistent hepatitis. J Hepatol 2:379\u2013388, 1986","journal-title":"J Hepatol"},{"key":"BF02090053_CR22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0168-8278(86)80048-4","volume":"2","author":"S Eriksson","year":"1986","unstructured":"Eriksson S, Zettervall O: TheN-terminal propeptide of collagen type III in serum as a prognostic indicator in primary biliary cirrhosis. J Hepatol 2:370\u2013378, 1986","journal-title":"J Hepatol"},{"key":"BF02090053_CR23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0168-8278(89)90049-4","volume":"9","author":"DJ Mutimer","year":"1989","unstructured":"Mutimer DJ, Bassendine MF, Kelly P, James OFW: Is measurement of type III procollagen aminopropeptide useful in primary biliary cirrhosis? J Hepatol 9:184\u2013189, 1989","journal-title":"J Hepatol"},{"key":"BF02090053_CR24","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(88)91843-0","volume":"1","author":"C Babbs","year":"1988","unstructured":"Babbs C, Hunt LP, Haboubi NY, Smith H, Rowan BP, Warnes TW: Type III procollagen peptide: A marker of disease activity and prognosis in primary biliary cirrhosis. Lancet 1:1021\u20131024, 1988","journal-title":"Lancet"},{"key":"BF02090053_CR25","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","volume":"98","author":"K Balasubramaniam","year":"1990","unstructured":"Balasubramaniam K, Grambsch PM, Wiesner RH, Lindor KD, Dickson ER: Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. Gastroenterology 98:1567\u20131571, 1990","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02090053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02090053\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02090053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T01:23:45Z","timestamp":1586395425000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02090053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["BF02090053"],"URL":"https:\/\/doi.org\/10.1007\/bf02090053","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,1]]}}}